Cargando…

Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients

BACKGROUND: Systemic lupus erythematosus (SLE) patients have a striking increase in cardiovascular (CV) comorbidity not fully explained by the Framingham risk score. Recent evidence from in vitro studies suggests that type I interferons (IFN) could promote premature CV disease (CVD) in SLE. We asses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Somers, Emily C., Zhao, Wenpu, Lewis, Emily E., Wang, Lu, Wing, Jeffrey J., Sundaram, Baskaran, Kazerooni, Ella A., McCune, W. Joseph, Kaplan, Mariana J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351452/ https://www.ncbi.nlm.nih.gov/pubmed/22606325 http://dx.doi.org/10.1371/journal.pone.0037000

Ejemplares similares

Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies
por: Marder, Wendy, et al.
Publicado: (2014)

'MiLES' population-based survey of the incidence and prevalence of systemic lupus erythematosus in Southeastern Michigan
por: Somers, EC, et al.
Publicado: (2012)

Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus
por: Sacre, Karim, et al.
Publicado: (2012)

Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival
por: Kazzaz, Nayef M, et al.
Publicado: (2015)

Incidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries
por: Izmirly, Peter M, et al.
Publicado: (2021)

Dietary Omega Polyunsaturated Fatty Acid Intake and Patient‐Reported Outcomes in Systemic Lupus Erythematosus: The Michigan Lupus Epidemiology and Surveillance Program
por: Charoenwoodhipong, Prae, et al.
Publicado: (2020)

Prescription Opioid Use in Patients With and Without Systemic Lupus Erythematosus — Michigan Lupus Epidemiology and Surveillance Program, 2014–2015
por: Somers, Emily C., et al.
Publicado: (2019)

Subclinical cardiovascular abnormalities in patients with juvenile systemic lupus erythematosus
por: Canpolat, Nur, et al.
Publicado: (2011)

The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus
por: Kahlenberg, J Michelle, et al.
Publicado: (2011)

Association between anti-interferon-alpha autoantibodies and COVID-19 in systemic lupus erythematosus
por: Gupta, Sarthak, et al.
Publicado: (2020)

Interferon Alpha in Systemic Lupus Erythematosus
por: Niewold, Timothy B., et al.
Publicado: (2010)

Interferon targeted therapies in systemic lupus erythematosus
por: Misra, Durga Prasanna, et al.
Publicado: (2017)

Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus
por: Smith, Michael A., et al.
Publicado: (2020)

Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy
por: Knight, Jason S, et al.
Publicado: (2014)

Periodontitis is associated with higher subclinical atherosclerosis in patients with systemic lupus erythematosus
por: Zamora‐Pasadas, Mónica, et al.
Publicado: (2022)

Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value
por: Hammad, Samar M., et al.
Publicado: (2021)

Serum α-chlorofatty acid as a biomarker for baseline subclinical cardiovascular disease in systemic lupus erythematosus
por: Mahieu, MA, et al.
Publicado: (2012)

Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
por: Bennett, Lynda, et al.
Publicado: (2003)

Systemic lupus erythematosus and the type I interferon system
por: Rönnblom, Lars, et al.
Publicado: (2003)

A longitudinal and transancestral analysis of DNA methylation patterns and disease activity in lupus patients
por: Coit, Patrick, et al.
Publicado: (2020)

Nocturnal blood pressure dipping as a marker of endothelial function and subclinical atherosclerosis in pediatric-onset systemic lupus erythematosus
por: Chang, Joyce C., et al.
Publicado: (2020)

Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic lupus erythematosus
por: Shehata, Ghaydaa A, et al.
Publicado: (2010)

Cardiac Manifestations in Systemic Lupus Erythematosus: Clinical Correlates of Subclinical Echocardiographic Features
por: Mohamed, Alaa A. A., et al.
Publicado: (2019)

Serum interleukin-18 and its relationship with subclinical atherosclerosis in systemic lupus erythematosus
por: Rezaieyazdi, Zahra, et al.
Publicado: (2021)

Subclinical retinopathy in systemic lupus erythematosus patients – optical coherence tomography study
por: Mimier-Janczak, Małgorzata Karolina, et al.
Publicado: (2023)

Native T1 mapping by cardiovascular resonance imaging detects subclinical cardiomyopathy in patients with systemic lupus erythematosus
por: Puntmann, Valentina O, et al.
Publicado: (2013)

Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus
por: Bauer, Jason W, et al.
Publicado: (2006)

A highlight from the LUPUS 2014 meeting: eight great ideas
por: Buyon, Jill P, et al.
Publicado: (2015)

Multiplex giant magnetoresistive biosensor microarrays identify interferon-associated autoantibodies in systemic lupus erythematosus
por: Lee, Jung-Rok, et al.
Publicado: (2016)

Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus
por: Cham, Candace M., et al.
Publicado: (2012)

Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus
por: Vázquez-Del Mercado, Mónica, et al.
Publicado: (2018)

Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus
por: Bhattacharya, Jyotsna, et al.
Publicado: (2018)

Diminished white matter integrity in patients with systemic lupus erythematosus
por: Schmidt-Wilcke, Tobias, et al.
Publicado: (2014)

Disease activity index is associated with subclinical atherosclerosis in childhood-onset systemic lupus erythematosus
por: Medeiros, Priscila B. S., et al.
Publicado: (2021)

DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus
por: Renauer, Paul, et al.
Publicado: (2015)

The Role of Circulating Regulatory T Cell Levels on Subclinical Atherosclerosis and Cardiovascular Risk Factors in Women with Systemic Lupus Erythematosus
por: García-Carrasco, Mario, et al.
Publicado: (2018)

The Role of Genetic Variation Near Interferon-Kappa in Systemic Lupus Erythematosus
por: Harley, Isaac T. W., et al.
Publicado: (2010)

Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus
por: Enocsson, Helena, et al.
Publicado: (2021)

Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile
Publicado: (1989)

Clinical and serological manifestations associated with interferon-α levels in childhood-onset systemic lupus erythematosus
por: Postal, Mariana, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vqhiaiplrf6o1vjksemg43uv1v